The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Expression of xCT and activity of system xc− are regulated by NRF2 in human breast cancer cells in response to oxidative stress
Open accessAbstract
Cancer cells adapt to high levels of oxidative stress in order to survive and proliferate by activating key transcription factors. One such master regulator, the redox sensitive transcription factor NF E2 Related Factor 2 (NRF2), controls the expression of cellular defense genes including those encoding intracellular redox-balancing proteins involved in glutathione (GSH) synthesis. Under basal conditions, Kelch-like ECH-associated protein 1 (KEAP1) targets NRF2 for ubiquitination. In response to oxidative stress, NRF2 dissociates from KEAP1, entering the nucleus and binding to the antioxidant response element (ARE) in the promoter of its target genes. Elevated reactive oxygen species (ROS) production may deplete GSH levels within cancer cells. System xc(-), an antiporter that exports glutamate while importing cystine to be converted into cysteine for GSH synthesis, is upregulated in cancer cells in response to oxidative stress. Here, we provided evidence that the expression of xCT, the light chain subunit of system xc(-), is regulated by NRF2 in representative human breast cancer cells. Hydrogen peroxide (H2O2) treatment increased nuclear translocation of NRF2, also increasing levels of xCT mRNA and protein and extracellular glutamate release. Overexpression of NRF2 up-regulated the activity of the xCT promoter, which contains a proximal ARE. In contrast, overexpression of KEAP1 repressed promoter activity and decreased xCT protein levels, while siRNA knockdown of KEAP1 up-regulated xCT protein levels and transporter activity. These results demonstrate the importance of the KEAP1/NRF2 pathway in balancing oxidative stress in breast cancer cells through system xc(-). We have previously shown that xCT is upregulated in various cancer cell lines under oxidative stress. In the current investigation, we focused on MCF-7 cells as a model for mechanistic studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Niture, S. K., Jain, A. K., & Jaiswal, A. K. (2009) · Journal of Cell Science · doi:10.1242/jcs.058537 · Cited by 192
RetractedModulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 3,007
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Mitsuishi, Y., Taguchi, K., Kawatani, Y., Shibata, T., Nukiwa, T., Aburatani, H., Yamamoto, M., & Motohashi, H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.016 · Cited by 1,395 · cited 2×
“Its knockdown by siRNA decreased tumor growth mediated by the pentose phosphate pathway [36].”
BackgroundKeap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S.-C., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,254
Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,109
Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway
Zhang, D. D. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600971974 · Cited by 1,086
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060
Venugopal, R., & Jaiswal, A. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14960 · Cited by 1,040
Kobayashi, A., Kang, M.-I., Watai, Y., Tong, K. I., Shibata, T., Uchida, K., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.221-229.2006 · Cited by 933
The role of glutathione in cancer
Balendiran, G. K., Dabur, R., & Fraser, D. (2004) · Cell Biochemistry and Function · doi:10.1002/cbf.1149 · Cited by 927
Shih, A. Y., Johnson, D. A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A., & Murphy, T. H. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03394.2003 · Cited by 785
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735 · cited 1×
“In breast and lung cancer cells, KEAP1 mutations impaired NRF2 repression [52,53].”
BackgroundChan, K., Lu, R., Chang, J. C., & Kan, Y. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13943 · Cited by 645
Superoxide radicals as precursors of mitochondrial hydrogen peroxide
Loschen, G., Azzi, A., Richter, C., & Flohé, L. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80281-4 · Cited by 634
Sasaki, H., Sato, H., Kuriyama-Matsumura, K., Sato, K., Maebara, K., Wang, H., Tamba, M., Itoh, K., Yamamoto, M., & Bannai, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208704200 · Cited by 542
Eggler, A. L., Liu, G., Pezzuto, J. M., van Breemen, R. B., & Mesecar, A. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502402102 · Cited by 456
Sun, Z., Huang, Z., & Zhang, D. D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006588 · Cited by 362
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin
Kim, Y. R., Oh, J. E., Kim, M. S., Kang, M. R., Park, S. W., Han, J. Y., Eom, H. S., Yoo, N. J., & Lee, S. H. (2010) · The Journal of Pathology · doi:10.1002/path.2653 · Cited by 358
Shih, A. Y., Erb, H., Sun, X., Toda, S., Kalivas, P. W., & Murphy, T. H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3178-06.2006 · Cited by 315
Hast, B. E., Goldfarb, D., Mulvaney, K. M., Hast, M. A., Siesser, P. F., Yan, F., Hayes, D. N., & Major, M. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4400 · Cited by 259
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
Singer, E., Judkins, J., Salomonis, N., Matlaf, L., Soteropoulos, P., McAllister, S., & Soroceanu, L. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.566 · Cited by 249
Li, L., Dong, H., Song, E., Xu, X., Liu, L., & Song, Y. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.12.005 · Cited by 247
Somatic mutations of the KEAP1 gene in common solid cancers
Yoo, N. J., Kim, H. R., Kim, Y. R., An, C. H., & Lee, S. H. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04178.x · Cited by 216
A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity
Nioi, P., & Nguyen, T. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.051 · Cited by 212
Ye, P., Mimura, J., Okada, T., Sato, H., Liu, T., Maruyama, A., Ohyama, C., & Itoh, K. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00221-14 · Cited by 208
Molecular Cloning and Expression of Human xCT, the Light Chain of Amino Acid Transport System x c ¯
Sato, H., Tamba, M., Kuriyama-Matsumura, K., Okuno, S., & Bannai, S. (2000) · Antioxidants & Redox Signaling · doi:10.1089/ars.2000.2.4-665 · Cited by 200
Inamdar, N. M., Ahn, Y. I., & Alam, J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0637 · Cited by 194
Jeyapaul, J., & Jaiswal, A. K. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00256-2 · Cited by 194
Glutathione levels and variability in breast tumors and normal tissue
Perry, R. R., Mazetta, J., Levin, M., & Barranco, S. C. (1993) · Cancer · doi:10.1002/1097-0142(19930801)72:3<783::aid-cncr2820720325>3.0.co;2-u · Cited by 191
Lewerenz, J., & Maher, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807325200 · Cited by 174
Patel, S. A., Warren, B. A., Rhoderick, J. F., & Bridges, R. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.006 · Cited by 164
Induction of cystine transport activity in mouse peritoneal macrophages.
Watanabe, H., & Bannai, S. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.3.628 · Cited by 160
Zhang, Y., Sano, M., Shinmura, K., Tamaki, K., Katsumata, Y., Matsuhashi, T., Morizane, S., Ito, H., Hishiki, T., Endo, J., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.05.011 · Cited by 156
Lewerenz, J., Klein, M., & Methner, A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03921.x · Cited by 149
Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway
Qaisiya, M., Zabetta, C. D. C., Bellarosa, C., & Tiribelli, C. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.029 · Cited by 146
Kim, J. Y., Kanai, Y., Chairoungdua, A., Ho, S., Matsuo, H., Kim, D. K., Inatomi, J., Sawa, H., Ida, Y., & Endou, H. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00338-8 · Cited by 143
Bannai, S. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43371-0 · Cited by 141
Cook, J. A., Pass, H. I., Iype, S. N., Friedman, N., DeGraff, W., Russo, A., & Mitchell, J. B. (1991) · PubMed · Cited by 135
Meijerman, I., Beijnen, J. H., & Schellens, J. H. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.002 · Cited by 132
Ni, M., Li, X., Yin, Z., Jiang, H., Sidoryk‐Wȩgrzynowicz, M., Milatović, D., Cai, J., & Aschner, M. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq126 · Cited by 118
Loignon, M., Miao, W., Hu, L., Bier, A., Bismar, T. A., Scrivens, P. J., Mann, K. K., Basik, M., Bouchard, A., Fiset, P., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1186 · Cited by 105
Regulation of xCT expression and system $$ x_{\text{c}}^{ - } $$ function in neuronal cells
Lewerenz, J., Maher, P. A., & Methner, A. (2011) · Amino Acids · doi:10.1007/s00726-011-0862-x · Cited by 93
ets‐1 is transcriptionally up‐regulated by H 2 O 2 via an antioxidant response element
Wilson, A., Gemin, A., Espiritu, R., & Singh, G. (2005) · The FASEB Journal · doi:10.1096/fj.05-4401fje · Cited by 86
Self-citationLimón-Pacheco, J. H., Hernández, N. A. H., Fanjul‐Moles, M. L., & Gonsebatt, M. E. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.06.028 · Cited by 83
Tsujita, T., Peirce, V. J., Baird, L., Matsuyama, Y., Takaku, M., Walsh, S. V., Griffin, J. L., Uruno, A., Yamamoto, M. P., & Hayes, J. D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00110-14 · Cited by 83
Qiang, W., Cahill, J. M., Liu, J., Kuang, X., Liu, N., Scofield, V. L., Voorhees, J. R., Reid, A. J., Yan, M., Lynn, W. S., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11926-11938.2004 · Cited by 78
Cancer cells release glutamate via the cystine/glutamate antiporter
Sharma, M. K., Seidlitz, E. P., & Singh, G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.168 · Cited by 76
Self-citationSeib, T., Patel, S. A., & Bridges, R. J. (2011) · Glia · doi:10.1002/glia.21176 · Cited by 73
Yang, Y., & Yee, D. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1803 · Cited by 68
Zhuang, C., Miao, Z., Sheng, C., & Zhang, W. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140217104648 · Cited by 68
Ungard, R. G., Seidlitz, E. P., & Singh, G. (2013) · Pain · doi:10.1016/j.pain.2013.08.030 · Cited by 67
Self-citationSatoh, T., Rezaie, T., Seki, M., Sunico, C. R., Tabuchi, T., Kitagawa, T., Yanagitai, M., Senzaki, M., Kosegawa, C., Taira, H., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07449.x · Cited by 66
Nandar, W., Neely, E. B., Unger, E., & Connor, J. R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.009 · Cited by 64 · cited 1×
“A correlation between NRF2 and xCT has been established in response to oxidative stress in a mouse model [16], and”
BackgroundBerger, S. J., Gosky, D. M., Zborowska, E., Willson, J. K. V., & Berger, N. A. (1994) · PubMed · Cited by 60
Alwi, S. S. S., Cavell, B. E., Donlevy, A. M., & Packham, G. (2012) · Cell Stress and Chaperones · doi:10.1007/s12192-012-0329-3 · Cited by 58
Ets-1 regulates intracellular glutathione levels: key target for resistant ovarian cancer
Verschoor, M. L., & Singh, G. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-138 · Cited by 56
Self-citationShiozaki, A., Iitaka, D., Ichikawa, D., Nakashima, S., Fujiwara, H., Okamoto, K. K., Kubota, T., Komatsu, S., Kosuga, T., Takeshita, H., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0847-5 · Cited by 52
Expression and function of cystine/glutamate transporter in neutrophils
Sakakura, Y., Sato, H., Shiiya, A., Tamba, M., Sagara, J., Matsuda, M., Okamura, N., Makino, N., & Bannai, S. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606385 · Cited by 52
Role of the transcription factor Ets-1 in cisplatin resistance
Wilson, A., Yamamoto, H., & Singh, G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.823.3.7 · Cited by 52
Self-citationSha, L. K., Sha, W., Kuchler, L., Daiber, A., Giegerich, A. K., Weigert, A., Knape, T., Snodgrass, R. G., Schröder, K., Brandes, R. P., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.004 · Cited by 50
Gjyshi, O., Flaherty, S., Veettil, M. V., Johnson, K. E., Chandran, B., & Bottero, V. (2014) · Journal of Virology · doi:10.1128/jvi.02742-14 · Cited by 44
Majid, A. S. A., Majid, A. M. S. A., Yin, Z., & Ji, D. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1034-z · Cited by 40
Linher‐Melville, K., & Singh, G. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-415 · Cited by 28
Self-citationLiu, M., Ravula, R., Wang, Z. K., Zuo, Z., Chow, M. S. S., Thakkar, A. D., Prabhu, S. V., Andresen, B. T., & Huang, Y. S. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-8 · Cited by 26
Ambient vapor samples activate the Nrf2-ARE pathway in human bronchial epithelial BEAS-2B cells
Shinkai, Y., Nakajima, S., Eiguren-Fernández, A., Distefano, E. W., Schmitz, D. A., Froines, J. R., Cho, A. K., & Kumagai, Y. (2013) · Environmental Toxicology · doi:10.1002/tox.21860 · Cited by 12
Cited by
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
The hallmarks of cancer metabolism: still emerging
Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.01.007 · Cited by 1,418
The Metabolic Underpinnings of Ferroptosis
Zheng, J., & Conrad, M. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.011 · Cited by 1,329
Ferroptosis is a type of autophagy-dependent cell death
Zhou, B., Liu, J., Kang, R., Klionsky, D. J., Kroemer, G., & Tang, D. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.03.002 · Cited by 1,061
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 692
Metadata
- Authors
- Habib, E., Linher-Melville, K., Lin, H.-X., & Singh, G.
- Venue
- Redox Biology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 5
- Pages
- 33-42
- ISSN
- 2213-2317 (ISSN-L)
- OpenAlex
- W2015360869
- Cited by
- 271
- References
- 66
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.